HIF1A and diabetic kidney disease: In experimental models of DKD, ROCK inhibition blunts the development of mesangial expansion, albuminuria, and glomerular hypertrophy without affecting metabolic factors (i.e., body weight, blood glucose levels, and blood pressure) via the downregulation of HIF-1α (8).